The crystal structure of spiro[2.2"]acenaphthene-1"-onespiro[3.3']-5'-(2,3-dichlorophenylmethylidene)-1'-methylpiperidin-4'-one-4-(2,3-dichorophenyl) octahydroindolizine was elucidated by single crystal X-ray diffraction. The title compound C 37 H 30 Cl 4 N 2 O 2 , crystallizes in the orthorhombic system, space group P2 1 2 1 2 1 with a = 8.4610(4) Å, b = 16.0926(6) Å, c = 23.8997(11) Å and Z = 4. The central piperidine ring adopts twisted conformation, the piperidine of octahydroindolizine ring is in chair conformation and the pyrrole ring is in slightly twisted envelope conformation. Details of the synthesis, NMR, crystal structure determination and intra-and intermolecular interactions of the compound are given.
Introduction
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB), which usually infects the lungs but may also affect the other parts of the body. This is one of the most prevalent diseases responsible for the death of approximately one billion people during the last two centuries. TB remains a severe public health problem in India accounting for nearly one-third of the global burden, and it has been estimated that 3.5 million of the population are infected with TB [1] . In the past years, only a few drugs have been approved by the Food and Drug Administration (FDA) to treat TB, which reflects the inherent difficulties in the discovery and clinical testing of new agents [2] . Hence, the discovery of fast-acting new drugs to effectively combat TB is imperative.
In general, spiro compounds [3, 4] and nitrogen heterocycles display good antimycobacterial activities [5] [6] [7] . Recently, Perumal et al. reported an atom economic synthesis and evaluation of antimycobacterial activities of spiro pyrido-pyrrolizines and pyrrolidines, [8, 9] which inhibited in vitro MTB and multi-drug resistant Mycobacterium tuberculosis (MDR-TB). In the course of screening to discover new compounds that could be useful for the treatment of TB, we herein report the synthesis, NMR spectra and single crystal X-ray studies of the title spiro compound.
Further it is also pertinent to note that the synthesis of biologically active indolizine derivatives continues to attract the attention of organic chemists, because of their wide spectrum of biological activity. Indolizine derivatives have been found to possess a variety of biological activities such as anti-inflammatory [10] , antiviral [11] , aromatase inhibitory [12] , analgesic and antitumor [13] activities. A brief survey of the Cambridge Structural Database (Version 5.33; [14] ) revealed a scarcity of precise crystallographic data on octahydroindolizine ring systems. Hence, this structure is presumed to be very interesting and rarely studied moieties. The chemical diagram of the title compound is shown in 2,3-dichlorophenylmethylidene]tetrahydro-4(1H)-pyridi none, an exocyclic dipolarophile, from the reaction of 1-methyl-4-piperidone and 2,3-dichlorobenzaldehyde in ethanol in the presence of NaOH. The cycloaddition of the above dipolarophile with azomethine ylide generated in situ from the decarboxylative condensation of acenaphthenequinone and piperidine-2-carboxylic acid led to the formation of the title compound in excellent yield.
A mixture of 1-methyl-3,5-bis[(E)-2,3-dichlorophenylmethylidene]tetrahydro-4(1H)-pyridinone (1 mmol), acenaphthenequinone (1 mmol) and piperidine-2-carboxylic acid (1 mmol) was dissolved in isopropyl alcohol (15 mL) and heated to reflux for 60 min. After completion of the reaction as evident from TLC, the mixture was poured into water (50 mL), the precipitated solid was filtered and washed with water (100 mL) to obtain the product as pure yellow solid. The product was recrystallized from ethyl acetate to obtain suitable crystals for the X-ray analysis. Melting point: 494 (2) K, Yield: 94%.
Structure Determination and Refinement
For the crystal structure determination, the intensity data of the single-crystal of the compound C 37 H 30 Cl 4 N 2 O 2 was collected using a Bruker AXS Kappa APEX II single crystal CCD Diffractometer equipped with graphitemonochromated MoKα radiation (λ = 0.71073 Å) at room temperature with a crystal dimension of 0.35 × 0.25 × 0.20 mm 3 . Accurate unit cell parameters were determined from the reflections of 36 frames measured in three different crystallographic zones. The data collection, data reduction and absorption correction were performed by APEX2, SAINT-plus and SADABS program [15] . The structure was solved by the direct method procedure and the non-hydrogen atoms were subjected to anisotropic refinement by full-matrix least squares on F 2 using SHELXL-97 program [16] . The positions of all the hydrogen atoms were identified from difference electron density map, and they were constrained to ride on the corresponding non-hydrogen atoms. Molecular graphics were drawn using PLATON [17] . The crystal data, experimental conditions and structure refinement parameters for the title compound are presented in Table 1 . 
Results and Discussion

Spectral Data
The structure of title compound has been elucidated with the help of 1 H, 13 C and two dimensional NMR spectroscopic studies. The H,H-COSY spectrum of the compound assigns a doublet and multiplet at 4.81 ppm (J = 9.9 Hz) and 4.00 ppm to H-4 and H-4a respectively.
Further It is pertinent to observe that the chemical shifts of 2'-CH 2 of the compound (2.95 ppm ~1.30 ppm) differ very much by 1.65 ppm. This suggests that probably the H-2eq is spatially proximate to the carbonyl of acenaphthylen-1(2H)-one shifting it downfield, while H-2ax lies in the shielding zone of the acenaphthylen-1(2H)-one ring shifting it downfield suggesting relative configuration at C-2 for the compound. The alternative stereochemistry with inversion of configuration at C-2 relative to that shown on the compound bringing both the carbonyls of the piperidone and acenapthene rings towards each other in spatial proximity, probably renders the transition state of the cycloaddition unstable by electrostatic repulsion. This could raise the free energy of activation (transition state B in Figure 3) , relative to the transition state leading to the formation of the compound with both carbonyls placed far off (transition state A in Figure 3 ). Figure 4 shows the ORTEP plot drawn at 50% probability displacement ellipsoids of title compound and the atom-numbering scheme. The six membered piperidine ring in the title compound adopts the half chair conformation as evident from puckering parameters Q = 0.561 (3) Å, θ = 136.9(3)˚ and Φ = 140.6(4)˚ [18] . The olefinic double bond in the structure has an E configuration. The piperidine of octahydroindolizine ring is in the chair conformation as evident from the puckering parameters Q = 0.574(2) Å, θ = 180(3)˚ and Φ = 69(11)˚ [18] . The pyrrole ring is in the twisted envelope conformation with atom N2 at the flap as the puckering parameters are, Q = 0.424(3) Å, and Φ = 12.2(4)˚ [18, 19] .
Crystal Structure
The dihedral angles between the mean plane of the piperidone ring and the aryl rings are 38.69(1)˚, 82.28(1)˚ which indicate that the aryl rings in the structure are not coplanar with the mean plane of the piperidone ring.
As a result, the torsion angle C3C31C32C33 is 41.24(3)˚. This lack of coplanarity is caused by nonbonded interactions between one of the ortho H atoms in the aryl ring and the equatorial H atoms at the 2-position of the piperidone ring (H33/H2A or H2B). As a result of these steric repulsions, the bond angle C3C31C32 expands to 128.69 ( . These values are in agreement with related structures [20] [21] [22] [23] [24] . The C8-N2 bond distance being 1.450 (3) Å is comparable to the C sp 2 -N sp 2 distances found in similar structures [25, 26] . In the crystal structure some weak C-H···O intramolecular interactions have been observed ( Table 2) . A C---H...π interaction ( Table 2 ) C10---H10B…Cg1, (Cg1 is the centroid of the ring C32-C37) forms, a two dimensional linear zig zag chain running parallel to the b-axis as shown in Figure 5. between the bond angle values and bio-activity [27] . In addition, the orientation of aryl rings will affect the alignment of these rings at a binding site and hence influence bioactivity [28] . Further studies on structurebioactivity relationship of this compound are in progress in our research group.
Conclusion
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